Logo image of HI.MI

HEALTH ITALIA SPA (HI.MI) Stock Fundamental Analysis

Europe - BIT:HI - IT0005585861 - Common Stock

285 EUR
0 (0%)
Last: 11/5/2025, 7:00:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to HI. HI was compared to 30 industry peers in the Health Care Providers & Services industry. HI scores excellent points on both the profitability and health parts. This is a solid base for a good stock. HI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

HI had positive earnings in the past year.
HI had a positive operating cash flow in the past year.
Each year in the past 5 years HI has been profitable.
In the past 5 years HI always reported a positive cash flow from operatings.
HI.MI Yearly Net Income VS EBIT VS OCF VS FCFHI.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

1.2 Ratios

With an excellent Return On Assets value of 6.33%, HI belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
Looking at the Return On Equity, with a value of 12.31%, HI is in the better half of the industry, outperforming 62.96% of the companies in the same industry.
HI has a better Return On Invested Capital (7.54%) than 74.07% of its industry peers.
The Average Return On Invested Capital over the past 3 years for HI is in line with the industry average of 6.66%.
The 3 year average ROIC (7.13%) for HI is below the current ROIC(7.54%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.33%
ROE 12.31%
ROIC 7.54%
ROA(3y)3.96%
ROA(5y)3.25%
ROE(3y)7.81%
ROE(5y)6.83%
ROIC(3y)7.13%
ROIC(5y)6%
HI.MI Yearly ROA, ROE, ROICHI.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 8.64%, HI belongs to the top of the industry, outperforming 92.59% of the companies in the same industry.
In the last couple of years the Profit Margin of HI has grown nicely.
HI's Operating Margin of 13.27% is amongst the best of the industry. HI outperforms 92.59% of its industry peers.
In the last couple of years the Operating Margin of HI has grown nicely.
Looking at the Gross Margin, with a value of 29.23%, HI is in line with its industry, outperforming 55.56% of the companies in the same industry.
In the last couple of years the Gross Margin of HI has remained more or less at the same level.
Industry RankSector Rank
OM 13.27%
PM (TTM) 8.64%
GM 29.23%
OM growth 3Y8%
OM growth 5YN/A
PM growth 3Y33.22%
PM growth 5Y9.47%
GM growth 3Y-1.7%
GM growth 5Y-0.8%
HI.MI Yearly Profit, Operating, Gross MarginsHI.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), HI is creating some value.
HI has more shares outstanding than it did 1 year ago.
The number of shares outstanding for HI has been reduced compared to 5 years ago.
HI has a better debt/assets ratio than last year.
HI.MI Yearly Shares OutstandingHI.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
HI.MI Yearly Total Debt VS Total AssetsHI.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

HI has an Altman-Z score of 3.09. This indicates that HI is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.09, HI belongs to the top of the industry, outperforming 85.19% of the companies in the same industry.
HI has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.30, HI belongs to the best of the industry, outperforming 92.59% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Altman-Z 3.09
ROIC/WACC1.02
WACC7.39%
HI.MI Yearly LT Debt VS Equity VS FCFHI.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

A Current Ratio of 2.47 indicates that HI has no problem at all paying its short term obligations.
HI has a Current ratio of 2.47. This is amongst the best in the industry. HI outperforms 96.30% of its industry peers.
HI has a Quick Ratio of 2.47. This indicates that HI is financially healthy and has no problem in meeting its short term obligations.
HI has a Quick ratio of 2.47. This is amongst the best in the industry. HI outperforms 96.30% of its industry peers.
Industry RankSector Rank
Current Ratio 2.47
Quick Ratio 2.47
HI.MI Yearly Current Assets VS Current LiabilitesHI.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

3

3. Growth

3.1 Past

HI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 81.67%, which is quite impressive.
HI shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 181.50% yearly.
The Revenue has decreased by -4.22% in the past year.
HI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.37% yearly.
EPS 1Y (TTM)81.67%
EPS 3Y27.76%
EPS 5Y181.5%
EPS Q2Q%27.61%
Revenue 1Y (TTM)-4.22%
Revenue growth 3Y-3.68%
Revenue growth 5Y2.37%
Sales Q2Q%1.23%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HI.MI Yearly Revenue VS EstimatesHI.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
HI.MI Yearly EPS VS EstimatesHI.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 5 10 15 20

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 17.58, which indicates a rather expensive current valuation of HI.
HI's Price/Earnings is on the same level as the industry average.
HI is valuated rather cheaply when we compare the Price/Earnings ratio to 26.06, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 17.58
Fwd PE N/A
HI.MI Price Earnings VS Forward Price EarningsHI.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HI is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.4
HI.MI Per share dataHI.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

HI has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.1
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HEALTH ITALIA SPA

BIT:HI (11/5/2025, 7:00:00 PM)

285

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap54.15M
Revenue(TTM)35.60M
Net Income(TTM)3.08M
Analysts84.44
Price Target372.3 (30.63%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 17.58
Fwd PE N/A
P/S 1.52
P/FCF N/A
P/OCF 42.82
P/B 2.17
P/tB 2.54
EV/EBITDA 9.4
EPS(TTM)16.21
EY5.69%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-7.46
FCFYN/A
OCF(TTM)6.66
OCFY2.34%
SpS187.37
BVpS131.59
TBVpS112.11
PEG (NY)N/A
PEG (5Y)0.1
Graham Number219.08
Profitability
Industry RankSector Rank
ROA 6.33%
ROE 12.31%
ROCE 13.76%
ROIC 7.54%
ROICexc 8.33%
ROICexgc 9.39%
OM 13.27%
PM (TTM) 8.64%
GM 29.23%
FCFM N/A
ROA(3y)3.96%
ROA(5y)3.25%
ROE(3y)7.81%
ROE(5y)6.83%
ROIC(3y)7.13%
ROIC(5y)6%
ROICexc(3y)7.88%
ROICexc(5y)6.76%
ROICexgc(3y)8.74%
ROICexgc(5y)7.6%
ROCE(3y)12.74%
ROCE(5y)10.6%
ROICexgc growth 3Y-3.65%
ROICexgc growth 5YN/A
ROICexc growth 3Y-1.37%
ROICexc growth 5YN/A
OM growth 3Y8%
OM growth 5YN/A
PM growth 3Y33.22%
PM growth 5Y9.47%
GM growth 3Y-1.7%
GM growth 5Y-0.8%
F-Score4
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Debt/EBITDA 1.28
Cap/Depr 242.82%
Cap/Sales 7.54%
Interest Coverage 250
Cash Conversion 21.7%
Profit Quality N/A
Current Ratio 2.47
Quick Ratio 2.47
Altman-Z 3.09
F-Score4
WACC7.39%
ROIC/WACC1.02
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)81.67%
EPS 3Y27.76%
EPS 5Y181.5%
EPS Q2Q%27.61%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.22%
Revenue growth 3Y-3.68%
Revenue growth 5Y2.37%
Sales Q2Q%1.23%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-16.56%
EBIT growth 3Y4.03%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-145.27%
FCF growth 3YN/A
FCF growth 5Y-21.09%
OCF growth 1Y-61.44%
OCF growth 3Y55.79%
OCF growth 5Y-20.58%

HEALTH ITALIA SPA / HI.MI FAQ

What is the ChartMill fundamental rating of HEALTH ITALIA SPA (HI.MI) stock?

ChartMill assigns a fundamental rating of 5 / 10 to HI.MI.


What is the valuation status for HI stock?

ChartMill assigns a valuation rating of 2 / 10 to HEALTH ITALIA SPA (HI.MI). This can be considered as Overvalued.


How profitable is HEALTH ITALIA SPA (HI.MI) stock?

HEALTH ITALIA SPA (HI.MI) has a profitability rating of 7 / 10.


What is the valuation of HEALTH ITALIA SPA based on its PE and PB ratios?

The Price/Earnings (PE) ratio for HEALTH ITALIA SPA (HI.MI) is 17.58 and the Price/Book (PB) ratio is 2.17.


Is the dividend of HEALTH ITALIA SPA sustainable?

The dividend rating of HEALTH ITALIA SPA (HI.MI) is 0 / 10 and the dividend payout ratio is 0%.